TABLE 1.
Variable | N | Data Before Imputation
|
Imputed Data (N = 871)
|
||||||
---|---|---|---|---|---|---|---|---|---|
Mean | SD | Min. | Max. | Mean | SD | Min. | Max. | ||
Dependent Variables | |||||||||
Meth UA Negative, One-Year Follow-up | 670 | 0.71 | – | 0 | 1 | 0.69 | – | 0 | 1 |
Meth UA Negative, Three-Year Follow-up | 480 | 0.74 | – | 0 | 1 | 0.71 | – | 0 | 1 |
Independent Variables | – | – | |||||||
Performance | |||||||||
Engagement | 871 | 0.32 | – | 0 | 1 | 0.32 | – | 0 | 1 |
Three Consecutive Negative Urines During Treatment | 871 | 0.42 | – | 0 | 1 | 0.42 | – | 0 | 1 |
Proportion of Expected Length of Treatment R Retained | 744 | 0.65 | 0.34 | 0 | 1.08 | 0.61 | 0.34 | 0 | 1.08 |
Demographics | |||||||||
Age | 871 | 32.9 | 7.93 | 18.1 | 56.5 | 32.9 | 7.93 | 18.1 | 56.5 |
Femalea | 871 | 1.57 | – | 1 | 2 | 1.57 | – | 1 | 2 |
White (vs. Other) | 871 | 0.63 | – | 0 | 1 | 0.63 | – | 0 | 1 |
Living Arrangement at Baseline (Vs. with Partner) | – | – | |||||||
No Partner, Alone or with Children | 869 | 0.15 | – | 0 | 1 | 0.15 | – | 0 | 1 |
With Others | 869 | 0.42 | – | 0 | 1 | 0.42 | – | 0 | 1 |
In Controlled Environment | 869 | 0.04 | – | 0 | 1 | 0.04 | – | 0 | 1 |
In an Unstable Situation | 869 | 0.06 | – | 0 | 1 | 0.06 | – | 0 | 1 |
Lived with AOD User at Baseline | 871 | 0.31 | – | 0 | 1 | 0.31 | – | 0 | 1 |
Usual Baseline Employment Status (vs. not Working) | – | – | |||||||
Full-time | 870 | 0.49 | – | 0 | 1 | 0.49 | – | 0 | 1 |
Part-time | 870 | 0.12 | – | 0 | 1 | 0.12 | – | 0 | 1 |
Substance Abuse History | |||||||||
# AOD Treatments between Baseline and One-Year Follow-up | 766 | 0.50 | 0.84 | 0 | 6 | 0.52 | 0.82 | 0 | 6 |
# AOD Treatments between Baseline and 3-Year Follow-up | 786 | 1.23 | 2.13 | 0 | 31 | 1.91 | 2.30 | 0 | 31 |
# Days in Past 30 used Meth at Baseline | 871 | 11.85 | 9.70 | 0 | 30 | 11.85 | 9.70 | 0 | 30 |
Note: SD = standard deviation, Min. = minimum, Max. = maximum. Standard deviations for dichotomous variables are not presented.
Male = 1, female = 2. Mean indicates that 57% of the sample is female.